The synthesis of novel organic compounds is key to progress in the discovery of effective anti-cancer drugs as well as drug candidate optimization. Organic synthesis is highly variable in terms of product yield, efficiency, compound stability, and ultimate utility for biological experiments. Once introduced in vivo, compounds have highly variable properties as far as stability, routes of elimination and metabolism.
Assist investigators with experimental plans for drug synthesis for lead optimization. Facilitate organic synthesis efforts through interactions with the Department of Chemistry, Industry or other collaborations. Provide support for grant submissions.
Director: Xiaobing Tian, PhD
Assistant Professor (Research)
Joint Program in Cancer Biology
Department of Pathology & Laboratory Medicine
Email: [email protected]